Methyl bacteriopurpurinimide
Term · Oncology and biomedicine · MLC-T-ONC-015132
A brain-penetrant bacteriochlorin analog and photosensitizer, with potential imaging and antineoplastic activities upon fluorescence imaging and fluorescence-guided photodynamic therapy (PDT) respectively. Upon administration, methyl bacteriopurpurinimide crosses the blood brain barrier (BBB) and is taken up by tumor cells. Upon clinical near-infrared (NIR) imaging, the tumor cells can be detected which allows for visualization of the tumor. Upon NIR PDT, the tumor cells are killed.
| Identifier | MLC-T-ONC-015132 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015132",
"term": "Methyl bacteriopurpurinimide",
"field": "Oncology and biomedicine",
"definition": "A brain-penetrant bacteriochlorin analog and photosensitizer, with potential imaging and antineoplastic activities upon fluorescence imaging and fluorescence-guided photodynamic therapy (PDT) respectively. Upon administration, methyl bacteriopurpurinimide crosses the blood brain barrier (BBB) and is taken up by tumor cells. Upon clinical near-infrared (NIR) imaging, the tumor cells can be detected which allows for visualization of the tumor. Upon NIR PDT, the tumor cells are killed.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/methyl-bacteriopurpurinimide/"
}
Record 10,945 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.